Literature DB >> 26464642

Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.

Woo Jung Sung1, Ki-Sung Park2, Sang Gyu Kwak3, Dae-Sung Hyun4, Jae Seok Jang5, Kwan-Kyu Park1.   

Abstract

Adenocarcinoma is the most common histologic type of non-small cell lung carcinomas. The existence of lung cancer stem cells (CSCs) and epithelial-mesenchymal transition (EMT) in human tissue is controversy. The aim of this study is to investigate the expression and clinical significance of CSCs and EMT markers and evaluate the correlation between the two in lung adenocarcinoma. A total of 97 cases comprise the tissue microarray from surgical resection for primary lung adenocarcinoma. Immunohistochemistry for ALDH1 and CD44 as CSC markers and E-cadherin, vimentin, fibronectin, SMA as EMT markers was performed. High ALDH1A1 expression was statistically associated with female gender (P=0.001), smoker (P=0.012), and high pT stages (P=0.046). High CD44 expression was statistically associated with female gender (P=0.008), non-smoker (P=0.000), and no pleural invasion (P=0.039). High expression of ALDH1 was associated with good overall survival (P=0.021). High expression of CD44 was correlated with both good overall survival (P=0.024) and disease-free survival (P=0.000). Vimentin expression was associated with pT stage (P=0.001) and pleural invasion (P=0.028). E-cadherin, fibronectin and SMA were not associated with clinicopathologic correlation and all EMT markers were not correlated with survival of lung adenocarcinoma. CSC markers expression was not related to EMT. Our results showed that the expression of CSCs was associated with a good prognosis in lung adenocarcinoma. The prognostic significance of EMT markers was skeptical in this study. There is a need for more research about CSC, EMT, and the relation between these two in human lung adenocarcinoma.

Entities:  

Keywords:  Lung cancer; adenocarcinoma; cancer stem cell; epithelial-mesenchymal transition; immunohistochemistry; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26464642      PMCID: PMC4583874     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  48 in total

Review 1.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

2.  Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties.

Authors:  Dario Ponti; Aurora Costa; Nadia Zaffaroni; Graziella Pratesi; Giovanna Petrangolini; Danila Coradini; Silvana Pilotti; Marco A Pierotti; Maria Grazia Daidone
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

3.  Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.

Authors:  Kazuhiko Shien; Shinichi Toyooka; Kouichi Ichimura; Junichi Soh; Masashi Furukawa; Yuho Maki; Takayuki Muraoka; Norimitsu Tanaka; Tsuyoshi Ueno; Hiroaki Asano; Kazunori Tsukuda; Masaomi Yamane; Takahiro Oto; Katsuyuki Kiura; Shinichiro Miyoshi
Journal:  Lung Cancer       Date:  2012-03-03       Impact factor: 5.705

4.  Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells.

Authors:  Venkata Lokesh Battula; Kurt William Evans; Brett George Hollier; Yuexi Shi; Frank C Marini; Ayyakkannu Ayyanan; Rui-Yu Wang; Cathrin Brisken; Rudy Guerra; Michael Andreeff; Sendurai A Mani
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

5.  Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

Authors:  Shih-Hwa Chiou; Mong-Lien Wang; Yu-Ting Chou; Chi-Jen Chen; Chun-Fu Hong; Wang-Ju Hsieh; Hsin-Tzu Chang; Ying-Shan Chen; Tzu-Wei Lin; Han-Sui Hsu; Cheng-Wen Wu
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

6.  Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance.

Authors:  Koji Okudela; Tetsukan Woo; Hideaki Mitsui; Michihiko Tajiri; Munetaka Masuda; Kenichi Ohashi
Journal:  Pathol Int       Date:  2012-12       Impact factor: 2.534

Review 7.  Cancer stem cell: implications in cancer biology and therapy with special reference to lung cancer.

Authors:  Hitoshi Kitamura; Koji Okudela; Takuya Yazawa; Hanako Sato; Hiroaki Shimoyamada
Journal:  Lung Cancer       Date:  2009-08-28       Impact factor: 5.705

8.  Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line.

Authors:  Jin Kyung Rho; Yun Jung Choi; Jin Kyung Lee; Baek-Yeol Ryoo; Im Il Na; Sung Hyun Yang; Cheol Hyeon Kim; Jae Cheol Lee
Journal:  Lung Cancer       Date:  2008-07-02       Impact factor: 5.705

9.  Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma.

Authors:  Yongli Shi; Hongyan Wu; Mingyi Zhang; Lei Ding; Fanqing Meng; Xiangshan Fan
Journal:  Diagn Pathol       Date:  2013-05-24       Impact factor: 2.644

10.  Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy.

Authors:  Scott J Dylla; Lucia Beviglia; In-Kyung Park; Cecile Chartier; Janak Raval; Lucy Ngan; Kellie Pickell; Jorge Aguilar; Sasha Lazetic; Stephanie Smith-Berdan; Michael F Clarke; Tim Hoey; John Lewicki; Austin L Gurney
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

View more
  10 in total

1.  Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression.

Authors:  Katsuaki Sato; Kenichi Suda; Shigeki Shimizu; Kazuko Sakai; Hiroshi Mizuuchi; Kenji Tomizawa; Toshiki Takemoto; Kazuto Nishio; Tetsuya Mitsudomi
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

2.  Combination Twist1 and CA15-3 in axillary lymph nodes for breast cancer prognosis.

Authors:  Xiaowei Jiang; Dan Guo; Wenfang Li; Tianwu Yu; Jian Zhou; Jianping Gong
Journal:  Mol Med Rep       Date:  2017-01-23       Impact factor: 2.952

3.  SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients.

Authors:  Camille Emprou; Pauline Le Van Quyen; Jérémie Jégu; Nathalie Prim; Noëlle Weingertner; Eric Guérin; Erwan Pencreach; Michèle Legrain; Anne-Claire Voegeli; Charlotte Leduc; Bertrand Mennecier; Pierre-Emmanuel Falcoz; Anne Olland; Nicolas Santelmo; Elisabeth Quoix; Gilbert Massard; Dominique Guenot; Marie-Pierre Chenard; Michèle Beau-Faller
Journal:  Cancer Med       Date:  2018-05-29       Impact factor: 4.452

4.  Overexpression of ALDH1 and EMT marker profile are linked with unfavorable outcome in head and neck cancer.

Authors:  V Vieira; L-H Campos; L-H Jesus; C Klabunde; T-D Gamba; I-L Flores; M-G Oliveira; P-V Rados
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-11-01

5.  Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.

Authors:  Zhihua Ye; Xin Zhang; Yihuan Luo; Shikang Li; Lanshan Huang; Zuyun Li; Ping Li; Gang Chen
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

6.  Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.

Authors:  Verena Tiran; Joerg Lindenmann; Luka Brcic; Ellen Heitzer; Stefanie Stanzer; Nassim Ghaffari Tabrizi-Wizsy; Elvira Stacher; Herbert Stoeger; Helmut H Popper; Marija Balic; Nadia Dandachi
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

7.  S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma.

Authors:  Ken Katono; Yuichi Sato; Makoto Kobayashi; Ryo Nagashio; Shinichiro Ryuge; Satoshi Igawa; Masaaki Ichinoe; Yoshiki Murakumo; Makoto Saegusa; Noriyuki Masuda
Journal:  Onco Targets Ther       Date:  2017-11-02       Impact factor: 4.147

8.  Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway.

Authors:  Chenhao Tong; Yali Wang; Jiandong Li; Wenda Cen; Weiguang Zhang; Zhiyang Zhu; Jianhua Yu; Baochun Lu
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

9.  C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomas.

Authors:  Binfeng Li; Zhengkai Xiang; Fei Xiong; Baoguo Yan; Qi Huang
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

10.  [Expression of CD44 in Tumor Tissue and Serum of Small Cell Lung Cancer and Its Clinical Prognostic Significance].

Authors:  Ying Wang; Yi Guo; Haifeng Lin; Lina Zhang; Hongmei Zhang; Qunhui Wang; Fanbin Hu; Jie Li; Baolan Li; Tongmei Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.